The Wilms' tumor gene WT1 can regulate genes involved in sex determination and differentiation: SRY, Mullerian-inhibiting substance, and the androgen receptor

Clinical Cancer Research

Volumn 3, Issue 12 II, 1997, Pages 2571-2580

  Shimamura, Ryuji ^a   Fraizer, Gail C ^a   Trapman, Jan ^b   Lau, Yun Fai C ^c   Saunders, Grady F ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; MUELLERIAN INHIBITING FACTOR;

ALTERNATIVE RNA SPLICING; CANCER GENETICS; CONFERENCE PAPER; DNA PROBE; ELECTROPHORETIC MOBILITY; EMBRYO DEVELOPMENT; GENE CONTROL; GENE REPRESSION; HUMAN; HUMAN CELL; NEPHROBLASTOMA; PRIORITY JOURNAL; PROMOTER REGION; SEX DETERMINATION; SEX DIFFERENTIATION; SEXUAL DEVELOPMENT; TRANSCRIPTION REGULATION;

ANIMALS; BASE SEQUENCE; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GENES, WILMS TUMOR; GLYCOPROTEINS; GROWTH INHIBITORS; HELA CELLS; HOMOZYGOTE; HUMANS; KIDNEY NEOPLASMS; MALE; MICE; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); RECEPTORS, ANDROGEN; SERTOLI CELLS; SEX DETERMINATION (GENETICS); SEX-DETERMINING REGION Y PROTEIN; TESTICULAR HORMONES; TESTIS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; WILMS TUMOR; WT1 PROTEINS;

EID: 0031417853     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (52)

1. Breslow, N. E., and Langholz, B. Childhood cancer incidence: geographical and temporal variations. Int. J. Cancer, 32: 703-716, 1983.
2. Breslow, N. E., Beckwith, J. B., Ciol, M., and Sharples, K. Age distribution of Wilms' tumor: report from the national Wilms' tumor study. Cancer Res., 48: 1653-1657, 1988.
3. Breslow, N. E., and Beckwith, J. B. Epidemiological features of Wilms' tumor: results of the National Wilms' tumor study. J. Natl. Cancer Instit., 68: 429-436, 1982.
4. Pelletier, J., Bruening, W., Kashtan, C. E., Mauer, S. M., Manivel, J. C., Striegel, J. E., Houghton, D. C., Junien, C., Habib, R., Fower, L., Fine, R. N., Silverman, B. L., Haber, D. A., and Housman, D. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell, 67: 437-447, 1991.
5. Bruening, W., Bardeesy, N., Silverman, B. L., Cohn, R. A., Machin, G. A., Aronson, A. J., Housman, D., and Pelletier, J. G. Germline intronic and exonic mutations in the Wilms' tumour gene (WT1) affecting urogenital development. Nat. Genet., 1: 144-148, 1992.
6. Moffett, P., Bruening, W., Nakagama, H., Bardeesy, N., Housman, D., Housman, D. E., and Pelletier, J. Antagonism of WT1 activity by protein self-association. Proc. Natl. Acad. Sci. USA, 92: 11105-11109, 1995.
7. Englert, C., Vidal, M., Maheswaran, S., Ge, Y., Ezzell, R. M., Isselbacher, K. J., and Haber, D. A. Truncated WT1 mutants alter the subnuclear localization of the wild-type protein. Proc. Natl. Acad. Sci. USA, 92: 11960-11964, 1995.
8. Haber, D. A., Sohn, R. L., Buckler, A. J., Pelletier, J., Call, K. M., and Housman, D. E. Alternative splicing and genomic structure of the Wilms' tumor gene WT1. Proc. Natl. Acad. Sci. USA, 88: 9618-9622, 1991.
9. Gessler, M., König, A., and Bruns, G. A. P. The genomic organization and expression of the WT1 gene. Genomics, 12: 807-813, 1992.
10. Bickmore, W. A., Oghene, K., Little, M. H., Seawright, A., van Heyningen, V., and Hastie, N. The candidate Wilms' tumour gene is involved in genitourinary development. Nature (Lond.), 346: 194-197, 1990.
11. Hewitt, S. M., Fraizer, G. C., Wu, Y-J., Rauscher, F. J., III, and Saunders, G. F. Differential function of Wilms' tumor gene WT1 splice isoforms in transcriptional regulation. J. Biol. Chem., 271: 8588-8592, 1996.
12. Rauscher, F. J., III, Morris, J. F., Tournay, O. E., Cook, D. M., and Curran, T. Binding of the Wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence. Science (Washington DC), 250: 1259-1262, 1990.
13. Pritchard-Jones, K., Fleming, S., Davidson, D., Bickmore, W., Porteous, D., Gosden, C., Bard, J., Buckler, A., Pelletier, J., Housman, D., van Heyningen, V., and Hastie, N. The candidate Wilms' tumour gene is involved in genitourinary development. Nature (Lond.), 346: 194-197, 1990.
14. Pelletier, J., Schalling, M., Buckler, A. J., Rogers, A., Haber, D. A., and Housman, D. Expression of the Wilms' tumor gene WT1 in the murine urogenital system. Genes Dev., 5: 1345-1356, 1991.
15. Armstrong, J. F., Pritchard-Jones, K., Bickmore, W. A., Hastie, N. D., and Bard, J. B. L. The expression of the Wilms' tumour gene, WT1, in the developing mammalian embryo. Mech. Dev., 40: 85-97, 1992.
16. Kreidberg, J. A., Sariola, H., Loring, J. M., Maeda, M., Pelletier, J., Housman, D., and Jaenisch, R. WT-1 is required for early kidney development. Cell, 74: 679-691, 1993.
17. Marx, J. Snaring the genes that divide the sexes for mammals. Science (Washington DC), 269: 1824-1825, 1995.
18. Bogan, J. S., and Page, D. C. Ovary? Testis? A mammalian dilemma. Cell, 76: 603-607, 1994.
19. Wang, Z-Y., Madden, S. L., Deuel, T. F., and Rauscher, F. J., III. The Wilms' tumor gene product, WT1, represses transcription of the platelet-derived growth factor A-chain gene. J. Biol. Chem., 267: 21999-22002, 1992.
20. Drummond, I. A., Madden, S. L., Rohwer-Nutter, P., Bell, G. I., Sukhatme, V. P., and Rauscher, F. J., III. Repression of the insulin-like growth factor II gene by the Wilms' tumor suppressor WT1. Science (Washington DC), 257: 674-678, 1992.
21. Dey, B. R., Sukhatme, V. P., Roberts, A. B., Sporn, M. B., Rauscher, F. J., III, and Kim, S-J. Repression of the transforming growth factor-β 1 gene by the Wilms' tumor suppressor WT1 gene product. Mol. Endcrinol., 8: 595-602, 1994.
22. Harrington, M. A., Konicek, B., Song, A., Xia, Z-L., Fredricks, W. J., and Rauscher, F. J., III. Inhibition of colony-stimulating factor-1 promoter activity by the product of the Wilms' tumor locus. J. Biol. Chem., 268: 1271-21275, 1993.
23. Werner, H., Rauscher, F. J., III., Sukhatme, V. P., Drummond, I. A., Roberts, C. T., and LeRoith, D. Transcriptional repression of the insulin-like growth factor I receptor (IGF-I-R) gene by the tumor suppressor WT1 involves binding to sequences both upstream and downstream of the IGF-I-R gene transcription start site. J. Biol. Chem., 269: 12577-12582, 1994.
24. Goodyer, P., Dehbi, M., Torban, E., Bruening, W., and Pelletier, J. Repression of the retinoic acid receptor-α gene by the Wilms' tumor suppressor gene product, wt1. Oncogene, 10: 1125-1129, 1995.
25. Ryan, G., Steele-Perkins, V., Morris, J. F., Rauscher, F. J., III, and Dressler, G. R. Repression of Pax-2 by WT1 during normal kidney development. Development (Camb.), 121: 867-875, 1995.
26. Hewitt, S. M., Hamada, S., McDonnell, T. J., Rauscher, F. J., III, and Saunders, G. F. Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms' tumor suppressor gene WT1. Cancer Res., 55: 5386-5389, 1995.
27. Su, H., and Lau, Y-F. C. Identification of the transcriptional unit, structural organization, and promoter sequence of the human sex-determining region Y (SRY) gene, using a reverse genetic approach. Am. J. Hum. Genet., 52: 24-38, 1993.
28. Faber, P. W., van Rooji, H. C. J., Schipper, H. J., Brinkmann, A. O., and Trapman, J. Two different, overlapping pathways of transcription initiation are active on the TATA-less human androgen receptor promoter. The role of Sp1. J. Biol. Chem., 268: 9296-9301, 1993.
29. Cate, R. L., Mattaliano, R. J., Hession, C., Tizard, R., Farber, N. M., Cheng, A., Ninfa, E. G., Frey, A. Z., Gash, D. J., Chow, E. P., Fisher, R. A., Bertonis, J. M., Torres, G., Wallner, B. P., Ramachandran, K. L., Ragin, R. C., Manganaro, T. F., MacLaughlin, D. T., and Donahoe, P. K. Isolation of the bovine and human genes for Müllerian inhibiting substance and expression of the human gene in animal cells. Cell, 45: 685-698, 1986.
30. Madden, S. L., Cook, D. M., Morris, J. F., Gashler, A., Sukhatme, V. P., and Rauscher, F. J., III. Transcriptional repression mediated by the WT1 Wilms' tumor gene product. Science (Washington DC), 253: 1550-1553, 1991.
31. Fraizer, G. C., Wu, Y-J., Hewitt, S. M., Maity, T., Ton, C. C. T., Huff, V., and Saunders, G. F. Transcriptional Regulation of the Human Wilms' Tumor Gene (WT1): constitutive Promoter and a Tissue Specific Enhancer. J. Biol. Chem., 269: 8892-8900, 1994.
32. Pavletich, N. P., and Pabo, C. O. Zinc finger-DNA recognition: crystal structure of a Zif268-DNA complex at 2.1A. Science (Washington DC), 252: 809-817, 1991.
33. Shen, W-H., Moore, C. C. D., Ikeda, Y., Parker, K. L., and Ingraham, H. A. Nuclear receptor steroidogenic factor 1 regulates the Müllerian inhibiting substance gene: a link to the sex determination cascade. Cell, 77: 651-661, 1994.
34. Mizokami, A., Yeh, S-Y., and Chang, C. Identification of 3′, 5′-cyclic adenosine monophosphate response element and other cis-acting elements in the human androgen receptor gene promoter. Mol. Endocrinol., 8: 77-88, 1994.
35. Maheswaran, S., Park, S., Bernard, A., Morris, J., Rauscher, F. J., III, Hill, D. E., and Haber, D. A. Physical and functional interaction between WT1 and p53 proteins. Proc. Natl. Acad. Sci. USA, 90: 5100-5104, 1993.
36. Sinclair, A. H., Berta, P., Palmer, M. S., Hawkins, J. R., Griffiths, B. L., Smith, M. J., Foster, J. W., Frischauf, A. M., Lovell-Badge, R., and Goodfellow, P. N. A gene from the human sex-determining region encodes a protein with homology to a conserved DNA binding motif. Nature (Lond.), 346: 240-244, 1990.
37. Koopman, P., Munsterberg, A., Capel, B., Vivian, N., and Lovell-Badge, R. Expression of a candidate sex-determining gene during mouse testis differentiation. Nature (Lond.), 348: 450-452, 1990.
38. Little, M., and Wells, C. A clinical overview of WT1 gene mutations. Hum. Mutat., 9: 209-225, 1997.
39. Behringer, R. R., Finegold, M. J., and Cate, R. L. Müllerian-inhibiting substance function during mammalian sexual development. Cell, 79: 415-425, 1994.
40. Hacker, A., Capel, B., Goodfellow, P., and Lovell-Badge, R. Expression of Sry, the mouse sex determining gene. Development (Camb.), 121: 1603-1614, 1994.
41. Vigier, B., Forest, M. G., Eychenne, B., Bezard, J., Garrigou, O., Robel, O., and Josso, N. Anti-Müllerian hormone produces endocrine sex reversal of fetal ovaries. Proc. Natl. Acad. Sci. USA, 86: 3684-3688, 1989.
42. Behringer, R. R., Cate, R. L., Froelick, G. T., Palmiter, R. D., and Brinster, R. L. Abnormal sexual development in transgenic mice chronically expressing Müllerian inhibiting substance. Nature (Lond.), 345: 167-170, 1990.
43. Reddy, J. C., Morris, J. C., Wang, J., English, M. A., Haber, D. A., Shi, Y., and Licht, J. D. WT1-mediated transcriptional activation is inhibited by dominant negative mutant proteins. J. Biol. Chem., 270: 10878-10884, 1995.
44. Carlson, B. M. In: Human Embryology and Development, pp. 352-360. St. Louis: Mosby-Year Book, Inc., 1994.
45. Sultan, C., Lobaccaro, J. M., Belon, C., Terraza, A., and Lumbroso, S. Molecular biology of disorders of sex differentiation. Horm. Res. (Basel), 38: 105-113, 1992.
46. Morris, J. M. The syndrome of testicular feminization in male pseudohermaphrodites. Am. J. Obstet. Gynecol., 65: 1192-1211, 1953.
47. Cooke, P. S., Young, P., and Cunha, G. R. Androgen receptor expression in developing male reproductive organs. Endocrinology, 128: 2867-2873, 1991.
48. Shan, L-X., Zhu, L-J., Bardin, W., and Hardy, M. P. Quantitative analysis of androgen receptor messenger ribonucleic acid in developing Leydig cells and Sertoli cells by in situ hybridization. Endocrinology, 136: 3856-3862, 1995.
49. Wang, Z-Y., Qui, Q-Q., and Duel, T. F. The Wilms' tumor gene product WT1 activates or suppresses transcription through separate functional domains. J. Biol. Chem., 268: 9172-9175, 1993.
50. Reddy, J. C., Hosono, S., and Licht, J. D. The transcriptional effect of WT1 is modulated by choice of expression vector. J. Biol. Chem., 270: 29976-29982, 1995.
51. Wang, Z-Y., Qui, Q-Q., Huang, J., Gurrieri, M., and Duel, T. F. Products of alternatively spliced transcripts of the Wilms' tumor suppressor gene, wt1, have altered DNA binding specificity and regulate transcription in different ways. Oncogene, 10: 415-422, 1995.
52. Larsson, S. H., Charlieu, J-P., Miyagawa, K., Engelkamp, D., Rassoulzadegan, M., Ross, A., Cuzin, F., van Heyningen, V., and Hastie, N. D. Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing. Cell, 81: 391-401, 1995.